With a market capitalization of Rs 15,993 crore, J B Chemicals and Pharmaceuticals Ltd. shares surged 8% on Thursday to reach an intraday high of  ₹ 2080 apiece from the previous close price of  ₹1923.

At 12.16 am, the stock was trading at Rs 2053.50 on the BSE, up 7 percent from its previous close.

One of the probable reasons for the stock to hit a high price is the company’s recent announcement of strong Q4 FY 22-23 earnings.


In addition, the company’s board recommended a final dividend of Rs 9.25 (462.50 percent) per equity share with a face value of Rs 2 for the years 2022-23. While the company also subdivided its shares at a ratio of 1:2. That means if 1 share is held by an investor it will become 2 shares.

J.B. Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest-growing pharmaceutical companies engaged in manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectables, and capsules.

Having a quick walkthrough of the financials reported by the company, In Q4FY23, PAT jumped 3.5% to ₹88 crores as against ₹85 crores in Q4FY22. Revenue stood at ₹762 crore, up by 22% from ₹625 crore in Q4FY22.

Zerodha banner mob

On a YoY comparison of the metrics, the revenues significantly improved from ₹2,424 crores during FY 21-22 to ₹3,149 crores in FY 22-23. The PAT numbers have shifted upwards within the timeframe mentioned, from ₹ 386 crores to 410 crores. 

According to the latest data pertaining to the shareholding pattern, promoters of the company hold a 53.93 percent stake, and domestic institutional investors (DIIs) hold a 19.08 percent stake in the company for FY 22-23.

Written by Omkar C


The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

To stay updated with the Latest Stock Market news, download our app here!

For editorial purposes, contact news@tradebrains.in

Start Your Stock Market Journey Today!

Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!